Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.

Jones, Rachel B ; Furuta, Shunsuke ; Cohen Tervaert, Jan Willem ; Hauser, Thomas ; Luqmani, Raashid ; Morgan, Matthew D ; Peh, Chen Au ; Savage, Caroline O ; Segelmark, Mårten LU and Tesar, Vladimir , et al. (2015) In Annals of the Rheumatic Diseases 74(6). p.1178-1182
Abstract
The RITUXVAS trial reported similar remission induction rates and safety between rituximab and cyclophosphamide based regimens for antineutrophil cytoplasm antibody (ANCA)-associated vasculitis at 12 months; however, immunosuppression maintenance requirements and longer-term outcomes after rituximab in ANCA-associated renal vasculitis are unknown.
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Annals of the Rheumatic Diseases
volume
74
issue
6
pages
1178 - 1182
publisher
BMJ Publishing Group
external identifiers
  • pmid:25739829
  • wos:000354371200034
  • scopus:84935002700
  • pmid:25739829
ISSN
1468-2060
DOI
10.1136/annrheumdis-2014-206404
language
English
LU publication?
yes
id
9e097ce3-c38b-4eaf-934f-05394a1e12df (old id 5265279)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25739829?dopt=Abstract
date added to LUP
2016-04-01 10:53:23
date last changed
2022-04-28 02:13:29
@article{9e097ce3-c38b-4eaf-934f-05394a1e12df,
  abstract     = {{The RITUXVAS trial reported similar remission induction rates and safety between rituximab and cyclophosphamide based regimens for antineutrophil cytoplasm antibody (ANCA)-associated vasculitis at 12 months; however, immunosuppression maintenance requirements and longer-term outcomes after rituximab in ANCA-associated renal vasculitis are unknown.}},
  author       = {{Jones, Rachel B and Furuta, Shunsuke and Cohen Tervaert, Jan Willem and Hauser, Thomas and Luqmani, Raashid and Morgan, Matthew D and Peh, Chen Au and Savage, Caroline O and Segelmark, Mårten and Tesar, Vladimir and van Paassen, Pieter and Walsh, Michael and Westman, Kerstin and Jayne, David Rw}},
  issn         = {{1468-2060}},
  language     = {{eng}},
  number       = {{6}},
  pages        = {{1178--1182}},
  publisher    = {{BMJ Publishing Group}},
  series       = {{Annals of the Rheumatic Diseases}},
  title        = {{Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.}},
  url          = {{http://dx.doi.org/10.1136/annrheumdis-2014-206404}},
  doi          = {{10.1136/annrheumdis-2014-206404}},
  volume       = {{74}},
  year         = {{2015}},
}